Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: padco who wrote (13190)	12/12/2003 4:40:02 AM
From: axial	Read Replies (2) \| Respond to of 14101

Padco, thanks for pointing out the new personnel at Dimethaid. I see the object of the current vilification campaign continues to attract capable personnel to her company. They must be a little hard of hearing, because they haven't heard the whispering campaigns. Obviously, those people haven't seen DMX investor threads, or the Globe & Mail. They're too dumb to know the company's drugs won't make it - because the CEO doesn't have a clue. Deaf, blind and dumb. That's what investors tell us these people must be. Not smart, capable people, making good career decisions. Just poor fools. She's criminally incompetent, and overpaid, according to investors. Was she "overpaid" when she was taking no salary at all? By implication, Cloutier is another dummy, on the compensation committee that approved her raise. Of course, the fact that her salary is about average - say 3 times a senior longshoreman's, or a tenth of a good hockey player. She's responsible for untold numbers of deaths, if you believe the current wisdom, by intentionally depriving Oxo Chemie of needed funds, and cutting out those who would have "saved the world" by swooping in late, and capitalizing on Dimethaid's funding. She didn't pour tens of millions of dollars into the company, and then act to preserve the investment of Dimethaid investors? Nope, guess not. She didn't get saddled with the mess of cleaning up a badly-mismanaged company, and its incomplete trials? Nope. She screwed everything up, according to investors. She wasn't the reason that Oxo Chemie got as far as it did? "No way!" they cry. Negativity is King these days, and anyone who dares to contradict the mob gets flamed. Too effin' bad. I haven't seen so much malicious, uninformed bull since Pravda stopped reviewing Capitalism. Some serious mistakes have been made at Dimethaid. They're being corrected. Dimethaid will be just fine. So will its drugs, and so will its new employees. Sorry to interrupt the negativity pump, but the past is not the future. Jim